Sarepta CFO shares withheld for RSU taxes

Sarepta Therapeutics, Inc. Chief Financial Officer Ryan Ho-Yan Wong reported a small share disposition tied to tax withholding, not an open-market trade.

Rhea-AI Filing Summary

Sarepta Therapeutics, Inc. Chief Financial Officer Ryan Ho-Yan Wong reported a small share disposition tied to tax withholding, not an open-market trade. On March 11, 256 shares of common stock were withheld by the company at $17.03 per share to cover taxes on restricted stock units that vested from a grant dated March 10, 2025.

After this tax-withholding event, Wong directly holds 135,064 shares of Sarepta common stock. Because the shares were withheld to satisfy tax obligations rather than sold in the market, this filing reflects a routine compensation-related adjustment rather than a discretionary purchase or sale.

Insider Trade Summary

Exercise Price or Tax Liability: 256 shares

Exercise Price or Tax Liability 1 txn

Insider Wong Ryan Ho-Yan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	256	$17.03	$4K

Holdings After Transaction: Common Stock — 135,064 shares (Direct)

Footnotes (1)

1. F1. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sarepta Therapeutics (SRPT) report for its CFO?

Sarepta’s CFO, Ryan Ho-Yan Wong, reported a routine tax-withholding transaction. The company withheld 256 common shares to cover taxes due on vested restricted stock units from a March 10, 2025 grant.

Was the Sarepta (SRPT) CFO’s Form 4 transaction an open-market sale?

No, the Form 4 transaction was not an open-market sale. The 256 shares were withheld by Sarepta to satisfy tax obligations from restricted stock unit vesting, a standard compensation-related adjustment rather than a discretionary share sale.

How many Sarepta (SRPT) shares does the CFO hold after this Form 4 event?

After the tax-withholding disposition, CFO Ryan Ho-Yan Wong directly holds 135,064 Sarepta common shares. This shows that the reported 256-share withholding is very small relative to his remaining equity position in the company.

What was the price used for the Sarepta (SRPT) CFO’s withheld shares?

The 256 shares withheld for tax obligations were valued at $17.03 per share. This price was used to determine the share amount needed to cover taxes arising from the vesting of restricted stock units granted on March 10, 2025.

What triggered the Sarepta (SRPT) CFO’s tax-withholding share disposition?

The disposition was triggered by the vesting of restricted stock units granted on March 10, 2025. To cover associated tax liabilities, Sarepta withheld 256 common shares from CFO Ryan Ho-Yan Wong instead of requiring a separate cash payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 08:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wong Ryan Ho-Yan

(Last) (First) (Middle)

215 FIRST STREET

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		F(1)		256	D	$17.03	135,064	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 10, 2025.

	/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ryan Ho-Yan Wong	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.